1. Home
  2. RVP vs SABS Comparison

RVP vs SABS Comparison

Compare RVP & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVP
  • SABS
  • Stock Information
  • Founded
  • RVP 1994
  • SABS 2014
  • Country
  • RVP United States
  • SABS United States
  • Employees
  • RVP N/A
  • SABS N/A
  • Industry
  • RVP Medical/Dental Instruments
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVP Health Care
  • SABS Health Care
  • Exchange
  • RVP Nasdaq
  • SABS Nasdaq
  • Market Cap
  • RVP 29.2M
  • SABS 31.2M
  • IPO Year
  • RVP 2001
  • SABS N/A
  • Fundamental
  • Price
  • RVP $0.82
  • SABS $3.14
  • Analyst Decision
  • RVP
  • SABS Strong Buy
  • Analyst Count
  • RVP 0
  • SABS 3
  • Target Price
  • RVP N/A
  • SABS $9.00
  • AVG Volume (30 Days)
  • RVP 229.4K
  • SABS 264.0K
  • Earning Date
  • RVP 11-14-2025
  • SABS 11-06-2025
  • Dividend Yield
  • RVP N/A
  • SABS N/A
  • EPS Growth
  • RVP N/A
  • SABS N/A
  • EPS
  • RVP N/A
  • SABS N/A
  • Revenue
  • RVP $38,161,712.00
  • SABS $114,698.00
  • Revenue This Year
  • RVP N/A
  • SABS N/A
  • Revenue Next Year
  • RVP N/A
  • SABS N/A
  • P/E Ratio
  • RVP N/A
  • SABS N/A
  • Revenue Growth
  • RVP N/A
  • SABS N/A
  • 52 Week Low
  • RVP $0.56
  • SABS $1.00
  • 52 Week High
  • RVP $1.14
  • SABS $6.60
  • Technical
  • Relative Strength Index (RSI)
  • RVP 40.91
  • SABS 61.94
  • Support Level
  • RVP $0.83
  • SABS $2.84
  • Resistance Level
  • RVP $0.89
  • SABS $3.34
  • Average True Range (ATR)
  • RVP 0.06
  • SABS 0.21
  • MACD
  • RVP -0.02
  • SABS -0.00
  • Stochastic Oscillator
  • RVP 8.99
  • SABS 60.34

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: